State Street Corp Bio Xcel Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 77,149 shares of BTAI stock, worth $25,459. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,149

Previous 124,749 38.16%

Holding current value

$25,459

Previous $159,000 70.44%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.53 - $1.34 $25,228 - $63,784	-47,600 Reduced 38.16%	77,149 $47,000
Q2 2024 Aug 14, 2024	SELL	$1.14 - $2.97 $387,781 - $1.01 Million	-340,159 Reduced 73.17%	124,749 $159,000
Q1 2024 May 15, 2024	BUY	$1.95 - $4.04 $47,923 - $99,287	24,576 Added 5.58%	464,908 $1.31 Million
Q4 2023 Feb 14, 2024	BUY	$2.32 - $5.51 $70,699 - $167,911	30,474 Added 7.44%	440,332 $1.3 Million
Q3 2023 Nov 14, 2023	SELL	$2.49 - $11.85 $4.14 Million - $19.7 Million	-1,662,341 Reduced 80.22%	409,858 $1.04 Million
Q2 2023 Aug 14, 2023	BUY	$6.39 - $28.58 $1.99 Million - $8.9 Million	311,516 Added 17.69%	2,072,199 $13.8 Million
Q1 2023 May 15, 2023	BUY	$17.7 - $33.24 $24.6 Million - $46.3 Million	1,392,114 Added 377.71%	1,760,683 $32.9 Million
Q4 2022 Feb 14, 2023	SELL	$10.25 - $22.43 $11,305 - $24,740	-1,103 Reduced 0.3%	368,569 $7.92 Million
Q3 2022 Nov 15, 2022	BUY	$11.19 - $17.89 $49,415 - $79,002	4,416 Added 1.21%	369,672 $4.37 Million
Q2 2022 Aug 15, 2022	SELL	$9.03 - $21.55 $9.35 Million - $22.3 Million	-1,035,497 Reduced 73.92%	365,256 $4.82 Million
Q1 2022 May 16, 2022	BUY	$15.0 - $22.83 $834,855 - $1.27 Million	55,657 Added 4.14%	1,400,753 $29.3 Million
Q4 2021 Feb 14, 2022	BUY	$20.12 - $35.09 $331,919 - $578,879	16,497 Added 1.24%	1,345,096 $27.3 Million
Q3 2021 Nov 15, 2021	SELL	$23.84 - $32.03 $3.11 Million - $4.18 Million	-130,516 Reduced 8.94%	1,328,599 $40.3 Million
Q2 2021 Aug 16, 2021	BUY	$29.06 - $38.83 $5.32 Million - $7.11 Million	183,209 Added 14.36%	1,459,115 $42.4 Million
Q1 2021 May 17, 2021	SELL	$39.04 - $64.6 $15.5 Million - $25.7 Million	-398,090 Reduced 23.78%	1,275,906 $55.1 Million
Q4 2020 Feb 16, 2021	BUY	$42.46 - $56.58 $16.1 Million - $21.5 Million	380,140 Added 29.38%	1,673,996 $77.3 Million
Q3 2020 Nov 10, 2020	BUY	$37.44 - $64.63 $12 Million - $20.6 Million	319,475 Added 32.79%	1,293,856 $56.1 Million
Q2 2020 Aug 14, 2020	BUY	$17.62 - $58.71 $14.9 Million - $49.8 Million	848,191 Added 672.15%	974,381 $51.7 Million
Q1 2020 May 11, 2020	BUY	$12.26 - $41.14 $1.55 Million - $5.19 Million	126,190 New	126,190 $2.82 Million

Others Institutions Holding BTAI

# of Institutions

Shares Held

3.11M

Call Options Held

22.2K

Put Options Held

40.2K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.25M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Bio Xcel Therapeutics, Inc. Transaction History